AVAI Bio, Inc. (AVAI) stock
AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
$0.11−0.00 (-1.75%)
Close on Oct 19, 2026Market cap $17.24MP/E –Yield –
AVAI Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AVAI Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.18M. For fiscal 2026 it was -$1.01M. The highest annual figure on record is $535.01K in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$1.01M | – |
| FY2025 | Mar 31, 2025 | -$1.16M | – |
| FY2024 | Mar 31, 2024 | -$1.32M | – |
| FY2023 | Mar 31, 2023 | -$54.46K | -110.2% |
| FY2022 | Mar 31, 2022 | $535.01K | +2217.1% |
| FY2021 | Mar 31, 2021 | $23.09K | -82.3% |
| FY2020 | Mar 31, 2020 | $130.72K | – |
| FY2019 | Mar 31, 2019 | -$84.17K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$414.26K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$50.83K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$347.13K | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$371.55K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$240.34K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$187.50K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$134.35K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$826.06K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$12.70K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$136.52K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$705.67K | -2265.6% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$420.40K | -612.4% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$59.73K | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$73.49K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $32.59K | -91.8% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $82.05K | -53.8% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$95.60K | -267.9% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$94.95K | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $395.34K | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $177.68K | +16.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $56.94K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$45.16K | -141.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$60.25K | -219.7% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $152.50K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$24.00K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $109.58K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $50.35K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$2.27K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$8.48K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$67.82K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$5.60K | – |
See a number that looks wrong?